Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

计划入组 10 人 · 首次发布于 2021 年 9 月 10 日

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

计划入组 1,530 人 · 首次发布于 2024 年 11 月 13 日

A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus

计划入组 9 人 · 首次发布于 2026 年 1 月 16 日

K1.1 mRNA

BCKDHA mRNA therapy (Moderna)

lipid nanoparticle-formulated mRNA vaccine

Lipid Therapeutics GmbH

Germany

Generation Bio

United States

Moderna, Inc.

United States

Sunshine Biopharma Advances K1.1 mRNA Lipid Nanoparticle Program Toward Dual-Therapy Strategy for Lung Cancer

Sunshine Biopharma's mRNA Therapy Shows Promise in Liver Cancer Treatment

Sunshine Biopharma's K1.1 mRNA Shows Promise in Treating Liver Cancer in Preclinical Studies